Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions
Clinical trial NCT02277704 · COMPLETED
Trial details
- NCT number
- NCT02277704
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2016-05-01
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.